A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo

Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
10/2011
10/27/2011	WO2011133115A1 Tumour radiolabelling imaging agents comprising ornithine and derivatives thereof
10/27/2011	WO2011131735A1 Cyclopentapeptide derivatives and uses thereof
10/27/2011	WO2011131731A1 Cyclopeptide derivatives and uses thereof
10/27/2011	WO2011100829A8 Bifunctional chelating agents
10/27/2011	WO2011039510A3 Conjugates targeting the cd163 receptor
10/27/2011	US20110264027 B ring reduced-d ring oxidized tetrapyrollic photosensitizers for photodynamic therapy and tumor imaging
10/27/2011	US20110262366 Compounds for targeting endothelial cells, compositions containing the same and methods for their use
10/27/2011	US20110262353 Muteins of hngal and related proteins with affinity for a given target
10/27/2011	US20110262352 Aryl piperazine and their use as alpha2c antagonists
10/27/2011	US20110262351 Fluorescent silica nanoparticle with radioactive tag and the detecting method of pet and fluorescent dual imaging using thereof
10/27/2011	US20110262349 Methods and Agents for the Diagnosis and Treatment of Hepatocellular Carcinoma
10/27/2011	US20110262348 Selective targeting of intratumoral cells
10/27/2011	US20110262347 Methods and compositions for enhanced delivery of compounds
10/26/2011	EP2380597A1 Cyclopeptide derivatives and uses thereof
10/26/2011	EP2380596A1 Cyclopentapeptide derivatives and uses thereof
10/26/2011	EP2380595A1 Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
10/26/2011	EP2380583A1 Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
10/26/2011	EP2379757A2 A method for the synthesis of a radionuclide-labeled compound
10/26/2011	EP2379493A1 Process for the preparation of asymmetrical bis(thiosemicarbazones)
10/26/2011	CN101486726B Coupling agent for preparing radiotherapy marker, 211At marker prepared thereby and preparation
10/26/2011	CN101381296B Method for synthesizing carbon nuclide (<11>C) labeled acetate
10/25/2011	US8044175 Peptides that specifically bind HGF receptor (CMET) and uses thereof
10/25/2011	US8044081 Aminoderivative of biotin and their conjugates with macrocyclic chelating agents
10/25/2011	US8044020 Pharmaceutical compositions and methods for insulin treatment
10/25/2011	US8044017 Ion exchange chromatography; gradient wash; resolution; remove impurities
10/25/2011	US8043601 Cyclic azapeptides as integrin markers
10/25/2011	CA2493109C Automated dynamic pressure-responsive hyperpolarized gas dispensing systems, and associated methods and computer program products
10/25/2011	CA2379974C Preparation of compounds useful for the detection of hypoxia
10/25/2011	CA2302228C Sterilized 5-aminolevulinic acid
10/20/2011	US20110257407 Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
10/20/2011	US20110257353 Polymer precursors of radiolabeled compounds, and methods of making and using the same
10/20/2011	US20110256057 Cyclic Azapeptides as Integrin Markers and Methods of Using
10/20/2011	US20110256056 Monoclonal Antibodies Against HER2 Antigens, and Uses Therefor
10/20/2011	US20110256055 Application of 99mtc peptide-based compound as a bone marrow imaging agent
10/20/2011	US20110256054 Compositions and Methods for the Treatment and Prevention of Lens Fibrotic Diseases
10/20/2011	US20110256053 Multiple Signaling Pathways Induced by Hexavalent, Monospecific and Bispecific Antibodies for Enhanced Toxicity to B-Cell Lymphomas and Other Diseases
10/20/2011	CA2795360A1 Tissue targeting
10/19/2011	CN102223905A Method for the production of scaffolds for tissue engineering, comprising the use of an anchoring unit, and scaffold produced therewith
10/19/2011	CN102223900A Imaging ligands
10/19/2011	CN102223899A Use of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazino[4,5-b]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels
10/19/2011	CN102219818A Thymidine derivates as well as preparation method and applications thereof in preparing tumor developing agents as ligand
10/19/2011	CN102219743A Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
10/18/2011	US8039585 for use in treatment and prevention of vision defects and cell proliferative disorders
10/18/2011	US8039582 Peptide networks
10/18/2011	US8039000 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
10/18/2011	US8038985 Pharmaceutical composition of nanoparticles
10/18/2011	US8038984 Membrane-permeant peptide complexes for treatment of sepsis
10/18/2011	US8038983 Fluorinated carbohydrate conjugates
10/18/2011	CA2589894C Radionuclide-chitosan complex having an improved stabilized gelatin in administering them to the body and their preparation method
10/18/2011	CA2221682C Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent
10/13/2011	WO2011127469A1 Radiopharmaceutical concentration measurement system and method
10/13/2011	WO2011127345A1 Synthesis of 18f-labeled tracers in hydrous organic solvents
10/13/2011	WO2011126010A1 Cancer cell-specific cell-penetrating peptide and use thereof
10/13/2011	US20110251486 Radiolabeled annexins
10/13/2011	US20110251136 Glue composition for lung volume reduction
10/13/2011	US20110250228 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
10/13/2011	US20110250137 Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation
10/13/2011	US20110250136 Fluorinated benzothiazole derivatives, preparation method thereof and imaging agent for diagnosing altzheimer's disease using the same
10/13/2011	US20110250135 Piperazine Derivatives for Binding and Imaging Amyloid Plaques and Their Use
10/13/2011	US20110250134 Sustained release nitric oxide from long lived circulating nanoparticles
10/13/2011	US20110250133 Gastrin releasing peptide compounds
10/13/2011	US20110250132 Lipoic acid metabolite: useful for drug carrier, nanoparticle conjugate, imaging and hyperthermia therapy
10/13/2011	US20110250131 Antigens Associated with Endometriosis, Psoriatic Arthritis and Psoriasis
10/13/2011	US20110250130 Tnf-alpha binding proteins
10/13/2011	US20110250129 Bioluminescence imaging-based screening assay and inhibitors of abcg2
10/13/2011	US20110250128 Method for tissue characterization based on beta radiation and coincident Cherenkov radiation of a radiotracer
10/13/2011	CA2795762A1 Synthesis of 18f-labeled tracers in hydrous organic solvents
10/13/2011	CA2795734A1 Tnf-.alpha. binding proteins
10/12/2011	EP2373622A2 Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer
10/12/2011	EP2373621A2 Technetium-and rhenium-bis(heteroaryl)complexes and methods of use thereof
10/12/2011	CN1925878B Contrast agents for myocardial perfusion imaging
10/12/2011	CN102212159A Preparation method and application of solid-phase organic tin compound
10/12/2011	CN101851313B Technetium-99m-marked poly N-vinyl benzyl-D-lactose amide composition and preparation method
10/12/2011	CN101486764B Technetium-99m marked 6-hydrazino pyridine-3-formamido novel lactose albumin complexes, preparation and use thereof
10/11/2011	US8034781 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth
10/11/2011	US8034351 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/11/2011	US8034314 Photoreactive compound specifically binding to calcium binding proteins
10/11/2011	CA2488584C Methods, mixtures, kits and compositions pertaining to analyte determination
10/11/2011	CA2486604C Recirculating target and method for producing radionuclide
10/11/2011	CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/11/2011	CA2378584C New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy
10/06/2011	WO2011123030A1 Nanoparticles comprising a core of amorphous rare earth element hydroxide and an organic coating
10/06/2011	WO2011123027A1 Improved treatment of renal cell carcinoma
10/06/2011	WO2011121276A1 Lipophilic cationic probe for pet- imaging
10/06/2011	WO2011045415A3 Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
10/06/2011	WO2011041319A8 Specific binding proteins and uses thereof
10/06/2011	US20110243846 Benzothiazole amides for detection of amyloid beta
10/06/2011	US20110243845 Somatostatin analogs with inhibitory activity to growth hormone release
10/06/2011	US20110243844 Sulfonamide derivative metabotropic glutamate r4 ligands
10/06/2011	US20110243843 Fluorescent silica nanoparticles for detecting lymph node and the identification method of lymph node using thereof
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	US20110243841 Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells
10/06/2011	US20110243840 Monoclonal antibodies against orthopoxviruses
10/06/2011	CA2795107A1 Lipophilic cationic probe for pet- imaging
10/06/2011	CA2794555A1 Improved treatment of renal cell carcinoma
10/06/2011	CA2794499A1 Antibody-based depletion of antigen-presenting cells and dendritic cells
10/05/2011	EP2371861A1 Monoclonal antibodies against extracellular loops of C5aR
10/05/2011	EP2370447A1 Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
10/05/2011	EP2370112A2 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone praticles as scaffolds for tissue regeneration
10/05/2011	EP2370111A1 Probe for a biological specimen and labelling method and screening method using the probe

1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 243